Skip to content

Clinical trials

Carcinoma, Squamous Cell trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Squamous Cell Country / region: United Kingdom Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20061
20082
20101
20111
20122
20143
20155
20161
20175
20183
20193
20201
20212
20223
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Terminated12
Recruiting4
Unknown status2
Active, not recruiting1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC3
PCI Biotech AS2
Smart Matrix Limited2
University College, London2
AVEO Pharmaceuticals, Inc.1
Ariad Pharmaceuticals1
BioVex Limited1
CMR Surgical Ltd1
Celgene1
Daiichi Sankyo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Squamous Cell38
Head and Neck Neoplasms11
Squamous Cell Carcinoma of Head and Neck10
Basal Cell Carcinoma6
Carcinoma, Non-Small-Cell Lung5
Keratosis, Actinic4
Adenocarcinoma3
Carcinoma, Large Cell3
Lung Neoplasms3
Neoplasm Metastasis3

Trials

Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.